Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 46Neoplasms 32Lung Neoplasms 24Colorectal Neoplasms 22Uterine Cervical Neoplasms 14Prostatic Neoplasms 13Motor Activity 11Colonic Neoplasms 10Anxiety Disorders 9Rectal Neoplasms 8Obesity 8Carcinoma, Non-Small-Cell Lung 8Pancreatic Neoplasms 7Hematologic Neoplasms 7Endometrial Neoplasms 7Depression 7Ovarian Neoplasms 6Lymphoma 6Breast Carcinoma In Situ 6Vulvar Neoplasms 5Urinary Bladder Neoplasms 5Neoplasm Metastasis 5Hematopoietic and Lymphatic System Neoplasm 5Triple Negative Breast Neoplasms 4Smoking Cessation 4Pain 4Melanoma 4Leukemia, Myeloid, Acute 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Neoplasms 4

Interventions

Standard of Care 2erythromycin propionate-N-acetylcysteinate 1Therapeutics 1Surgical Procedures, Operative 1Practice Guidelines as Topic 1Palliative Care 1Methods 1Mass Screening 1Genes, p53 1Focus Groups 1Dignity Therapy 1Coping Skills 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Death × Methods × Clear all
NCT00106067 2015-04-07

A&SC

VA Office of Research and Development

Phase NA Completed
559 enrolled

Death, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡